BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows 
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026 
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
BlueScope Steel Announces A$1 Special Dividend After Asset Sales 
LAGUNA HILLS, Calif., March 30, 2017 -- Sonendo® Inc. the developer of a breakthrough technology for the dental marketplace, announced today that it will be presenting at the upcoming Needham Healthcare Conference in New York, NY on Wednesday, April 5th, 2017.
The Company’s presentation, to be delivered by President and CEO, Bjarne Bergheim, is scheduled for 10:00 a.m. Eastern Time. About the event, Bjarne Bergheim stated, “We look forward to participating in this year's conference and providing an update on the commercial activation of our GentleWave® System. This includes a presentation of results from both the GentleWave® patient and provider experience as we continue to pursue our mission of Saving Teeth Through Sound Science®.”
About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to standard root canal techniques1-2. For more information, please visit www.sonendo.com.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions, and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
